Does cotrimoxazole prophylaxis in HIV patients increase the drug resistance of pneumococci? A comparative cross-sectional study in southern Ethiopia.

Does cotrimoxazole prophylaxis in HIV patients increase the drug resistance of pneumococci? A comparative cross-sectional study in southern Ethiopia.

<h4>Background</h4>Infections caused by antibiotic-resistant bacteria results in high rates of morbidity and mortality. Although the prolonged cotrimoxazole (CTX) prophylaxis is arguably associated with the risk of increasing drug resistance in the common pathogens, information regarding...

Full description

Bibliographic Details
Main Authors: Mohammed Seid, Getnet Beyene, Yared Alemu, Bereket Workalemahu, Mulugeta Delbo, Dagimawie Taddesse, Gelila Biresaw, Aseer Manilal
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0243054

Internet

https://doi.org/10.1371/journal.pone.0243054

Similar Items